Norgestimate and Ethinyl Estradiol
- Product NDC
- 68788-7302
- 11-digit product format
- 687887302
- Labeler code
- 68788
- Product ID
- 68788-7302_29ca7811-d6f0-4763-9002-f3868a8aa388
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Norgestimate and Ethinyl Estradiol
- Dosage form
- KIT
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA200494
- Marketing category
- ANDA
- Marketing start
- 2019-01-03
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68788-7302 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 68788-7302 | 68788-7302-2 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200494-001 | NORGESTIMATE AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; NORGESTIMATE | 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG | TABLET / ORAL-28 | AB | RS | 2011-06-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A200494-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A200494-001 | NORGESTIMATE AND ETHINYL ESTRADIOL | 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG | TABLET / ORAL-28 | AB | RS | 2011-06-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A200494-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 8b247e46-203e-4f5b-b5a7-cbd57341c735 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 200494 ANDA200494 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 6ae97238-28cf-4bc9-a4ba-1e2bf4e3c600 | 2023-03-28 | Boxed warning, Warnings, Adverse reactions | 200494 ANDA200494 |
| Norgestimate and Ethinyl Estradiol | NORGESTIMATE AND ETHINYL ESTRADIOL | Proficient Rx LP | 4a159dcd-8af4-4e59-8f46-7b0fe5c22807 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 200494 ANDA200494 |